Human colon adenocarcinoma in the SCID/CB6 radiation chimera is susceptible to adoptive transfer of allogeneic human peripheral blood mononuclear cells

Journal of Hematotherapy and Stem Cell Research

Volumn 11, Issue 6, 2002, Pages 883-893

  Arditti, Fabian D ^a   Greenberg, Ron ^b   Dekel, Benjamin ^a   Marcus, Hadar ^a   Nagler, Arnon ^c   Berrebi, Alain ^d   Skornick, Yehuda ^b   Reisner, Yair ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

^c SHEBA MEDICAL CENTER   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; TUMOR MARKER;

ADOPTIVE IMMUNOTHERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN DETECTION; ARTICLE; CANCER INHIBITION; CANCER INVASION; CELL INFILTRATION; CELL TRANSPLANTATION; COLON ADENOCARCINOMA; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; EFFECTOR CELL; LUNG METASTASIS; MONONUCLEAR CELL; MOUSE; NEPHRECTOMY; NONHUMAN; PATIENT MONITORING; PERITONEAL CAVITY; PRIORITY JOURNAL; RADIATION CHIMERA; TUMOR GROWTH; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BONE MARROW TRANSPLANTATION; COLONIC NEOPLASMS; HUMANS; IMMUNOTHERAPY, ADOPTIVE; LEUKOCYTES, MONONUCLEAR; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MICE, SCID; NEPHRECTOMY; TRANSPLANTATION CHIMERA; TRANSPLANTATION, HETEROLOGOUS; TREATMENT OUTCOME;

EID: 0036975251     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/152581602321080547     Document Type: Article

References (39)

1. Armstrong AC, D Eaton and JC Ewing. (2001). Science, medicine, and the future: Cellular immunotherapy for cancer. Br Med J 323:1289-1293.
2. Murphy WJ, TC Back, KC Conlon, KL Komschlies, JR Ortaldo, TJ Sayers, RH Wiltrout and DL Longo. (1993). Antitumor effects of interleukin-7 and adoptive immunotherapy on human colon carcinoma xenografts. J. Clin Invest 92:1918-1924.
3. Lefrancois D, S Olschwang, O Delattre, M Muleris, AM Dutrillaux, G Thomas and B Dutrillaux. (1989). Preservation of chromosome and DNA characteristics of human colorectal adenocarcinomas after passage in nude mice. Int J Cancer 44:871-878.
4. Jewett MA. (1978). Testis carcinoma: transplantation into nude mice. Natl Cancer Inst Monogr 49:65-66.
5. Klein KA, RE Reiter, J Redula, H Moradi, XL Zhu, AR Brothman, DJ Lamb, M Marcelli, A Belldegrun, ON Witte and CL Sawyers. (1997). Progression of metastatic human prostate cancer to androgen independence in immunodeficient SCID mice. Nature Med 3:402-408.
6. Kubota T, H Yamaguchi, M Watanabe, T Yamamoto, T Takahara, T Takeuchi, T Furukawa, S Kase, S Kodaira, K Ishibiki et al. (1993). Growth of human tumor xenografts in nude mice and mice with severe combined immunodeficiency (SCID). Surg Today 23:375-377.
7. Conway TF Jr., MS Sabel, M Sugano, JG Frelinger, NK Egilmez, F Chen and RB Bankert. (2000). Growth of human tumor xenografts in SCID mice quantified using an immunoassay for tumor marker protein in serum. J Immunol Methods 233:57-65.
8. Tueni EA, P Dumont, D Jacobovitz, G Atassi, P Rocmans, F Lejeune, P de Franquen, P Semal and J Klastersky. (1987). Subrenal capsule assay for fresh human tumors in immunocompetent mice; an inappropriate technique for non-small cell lung cancer. Eur J Cancer Clin Oncol 23:1163-1167.
9. Bennett JA, VA Pilon and RT MacDowell. (1985). Evaluation of growth and histology of human tumor xenografts implanted under the renal capsule of immunocompetent and immunodeficient mice. Cancer Res 45:4963-4969.
10. Bogden AE, WR Cobb, DJ Lepage, PM Haskell, TA Gulkin, A Ward, DE Kelton and HJ Esber. (1981). Chemotherapy responsiveness of human tumors as first transplant generation xenografts in the normal mouse: six-day subrenal capsule assay. Cancer 48:10-20.
11. Lubin I, H Segall, H Marcus, M David, L Kulova, M Steinitz, P Erlich, J Gan and Y Reisner. (1994). Engraftment of human peripheral blood lymphocytes in normal strains of mice. Blood 83:2368-2381.
12. Lubin I, H Segall, P Erlich, M David, H Marcus, G Fire, T Burakova, L Kulova and Y Reisner. (1995). Conversion of normal rats into SCID-like animals by means of bone marrow transplantation from SCID donors allows engraftment of human peripheral blood mononuclear cells. Transplantation 60:740-747.
13. Burakova T, H Marcus, A Canaan, B Dekel, E Shezen, M David, I Lubin, H Segal and R Yair. (1997). Engrafted human T and B lymphocytes form mixed follicles in lymphoid organs of human/mouse and human/rat radiation chimera. Transplantation 63:1166-1171.
14. Marcus H, T Burakova, E Shezen, M David, A Canaan, I Lubin and Y Reisner. (1996). Human → mouse radiation chimera do not develop Epstein-Barr virus lymphoma. Immunol Lett 49:155-161.
15. Marcus H, M David, A Canaan, L Kulova, I Lubin, H Segall, L Denes, P Erlich, E Galun, J Gan and et al. (1995). Human/mouse radiation chimera are capable of mounting a human primary humoral response. Blood 86:398-406.
16. Segall H, I Lubin, H Marcus, A Canaan and Y Reisner. (1996). Generation of primary antigen-specific human cytotoxic T lymphocytes in human/mouse radiation chimera. Blood 88:721-730.
17. Dekel B, T Burakova, H Marcus, E Shezen, S Polack, A Canaan, J Passwell and Y Reisner. (1997). Engraftment of human kidney tissue in rat radiation chimera: I. A new model of human kidney allograft rejection. Transplantation 64:1541-1550.
18. Arditti FD, S Aviner, R Krauthgamer, J Gan, H Gur, A Nagler, Y Yitzchak, J Stein, J Rowe, A Tabilio, M Martelle, A Berrebi and Y Reisner. (2000). Anti-3rd party human CTLs generated from autologous or allogeneic T cells are endowed with potent GVL activity in the absence of GVHD [abstract]. Blood 96:174a.
19. Takahashi H, T Nakada and I Puisieux. (1993). Inhibition of human colon cancer growth by antibody-directed human LAK cells in SCID mice. Science 259:1460-1463.
20. Fidler IJ. (1991). Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer Metastasis Rev 10:229-243.
21. Kitadai Y, R Radinsky, CD Bucana, Y Takahashi, K Xie, E Tahara and IJ Fidler. (1996). Regulation of carcinoembryonic antigen expression in human colon carcinoma cells by the organ microenvironment. Am J Pathol 149:1157-1166.
22. Takahashi Y, LM Ellis, MR Wilson, CD Bucana, Y Kitadai and IJ Fidler. (1996). Progressive upregulation of metastasis-related genes in human colon cancer cells implanted into the cecum of nude mice. Oncol Res 8:163-169.
23. Fidler IJ, C Wilmanns, A Staroselsky, R Radinsky, Z Dong and D Fan. (1994). Modulation of tumor cell response to chemotherapy by the organ environment. Cancer Metastasis Rev 13:209-222.
24. Nakajima M, K Morikawa, A Fabra, CD Bucana and IJ Fidler. (1990). Influence of organ environment on extracellular matrix degradative activity and metastasis of human colon carcinoma cells. J Natl Cancer Inst 82:1890-1898.
25. Williams SS, TR Alosco, BA Croy and RB Bankert. (1993). The study of human neoplastic disease in severe combined immunodeficient mice. Lab Anim Sci 43:139-146.
26. Eccles SA, G Box, W Court, J Sandle and CJ Dean. (1994). Preclinical models for the evaluation of targeted therapies of metastatic disease. Cell Biophys 24-25:279-291.
27. Morecki S, Y Moshel, Y Gelfend, T Pugatsch and S Slavin. (1997). Induction of graft vs. tumor effect in a murine model of mammary adenocarcinoma. Int J Cancer 71:59-63.
28. Morecki S, E Yacovlev, A Diab and S Slavin. (1998). Allogeneic cell therapy for a murine mammary carcinoma. Cancer Res 58:3891-3895.
29. Porter DL. (2001). The graft-versus-tumor potential of allogeneic cell therapy: an update on donor leukocyte infusions and nonmyeloablative allogeneic stem cell transplantation. J Hematother Stem Cell Res 10:465-480.
30. Childs R and J Barrett. (2002). Nonmyeloablative stem cell transplantation for solid tumors: Expanding the application of allogeneic immunotherapy. Semin Hematol 39:63-71.
31. Teshima T, C Liu, KP Lowler, G Dranoff and JL Ferrara. (2002). Donor leukocyte infusion from immunized donors increases tumor vaccine efficacy after allogeneic bone marrow transplantation. Cancer Res 62:796-800.
32. Margolin KA. (2001). Autologous and allogeneic high-dose therapy for melanoma. Curr Oncol Rep 3:338-343.
33. Childs R, A Chemoff, N Contentin, E Bahceci, D Schrump, S Leitman, EJ Read, J Tisdale, C Dunbar, WM Linehan, NS Young and AJ Barrett. (2000). Regression of metastatic renal-cell carcinoma after nonmyeloablative allogeneic peripheral-blood stem-cell transplantation. N Engl J Med 343:750-758.
34. Murphy WJ, CY Koh, A Raziuddin, M Bennett and DL Longo. (2001). Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies. Immunol Rev 181:279-289.
35. Ruggeri L, M Capanni, MF Martelli and A Verlardi. (2001). Cellular therapy: exploiting NK cell alloreactivity in transplantation. Curr Opin Hematol 8:355-359.
36. Bachar-Lustig E, HW Li, H Gur, R Krauthgamer, H Marcus and Y Reisner. (1999). Induction of donor-type chimerism and transplantation tolerance across major histocompatibility barriers in sublethally irradiated mice by Sca-1(+)Lin(-) bone marrow progenitor cells: synergism with non-alloreactive (host X donor)F(1) T cells. Blood 94:3212-3221.
37. Valteau-Couanet D, M Cavazzana-Calvo, F Le Deist, C Fromont and A Fischer. (1993). Functional study of residual T lymphocytes after specific elimination of alloreactive T cells by a specific anti-interleukin-2 receptor Bk chain immunotoxin. Transplantation 56:1574-1576.
38. Montagna D, E Yvon, V Calcaterra, P Comoli, F Locatelli, R Maccario, A Fisher and M Cavazzana-Calvo. (1999). Depletion of alloreactive T cells by a specific antiinterleukin-2 receptor p55 chain immunotoxin does not impair in vitro antileukemia and antiviral activity. Blood 93:3550-3557.
39. Guinan EC, VA Boussiotis, D Neuberg, LL Brennan, N Hirano, LM Nadler and JG Gribben. (1999). Transplantation of anergic histoincompatible bone marrow allografts. N Engl J Med 340:1704-1714.